Back

CBD Oil

CBD oil is widely recognized for its potential to support relaxation and manage everyday stress.

Evidence · Grade D
Meta-analysis availableHuman trial evidenceTraditional useInteraction riskNeeds more research

Non-intoxicating cannabinoid from hemp studied for anxiety, sleep, MS-related spasticity, and pediatric seizures.

CBD oil, derived from the cannabis plant, is a non-intoxicating compound studied for various health applications. It is commonly used by individuals seeking support for feelings of unease, occasional discomfort, and to promote overall well-being. People typically consume CBD oil sublingually (under the tongue) using a dropper, or it can be found in capsules, edibles, and topical forms.

Quick answer

What it is: CBD oil, derived from the cannabis plant, is a non-intoxicating compound studied for various health applications.

May support:Insomnia, Anxiety

Evidence:Evidence · Grade D

Evidence Summary

Evidence · Grade D

Evidence for CBD's effects includes a growing number of human clinical trials, observational studies, and extensive preclinical research. The evidence grade of B suggests a good body of research supporting some applications, though often with limitations.

Last reviewed · Jun 2026

Have you tried CBD Oil?

Vote in 5 seconds. Add details if you want.

Your experience for Insomnia:

Commonly Combined With

Other remedies frequently used alongside this one — from curated relationships, community reports, and shared protocols.

Community signal breakdown

Where this remedy is being discussed across the web and community.

People Like Me insights

As more members share outcomes, RemedyAtlas will show which remedies helped people with similar conditions, symptoms, goals, and lab patterns.

Community Discussions

What people say about CBD Oil

Search on Reddit →

Latest News

Latest news on CBD Oil

More on Google News →

Health Videos

Health videos on CBD Oil

More on YouTube

Why It Works

CBD appears to interact with the body's endocannabinoid system, a complex network involved in regulating various physiological processes. It may also influence other receptor systems to exert its effects.

How it works in more detail

CBD is thought to modulate endocannabinoid tone indirectly, rather than binding strongly to CB1 or CB2 cannabinoid receptors. Preclinical studies suggest it may interact with serotonin 5-HT1A receptors, which are implicated in mood regulation. Additionally, CBD has been studied for its potential to impact transient receptor potential vanilloid 1 (TRPV1) channels and to influence inflammatory cytokine production, actions primarily observed in preclinical models.

How to use

Always consult a qualified clinician.

Editorial guidance

Suggested dosage
10–50 mg CBD, 1–2x/day; titrate up as needed.
Research dosage range
20–600 mg/day
Typical onset
The onset of effects for sublingual CBD oil can typically range from 15 minutes to an hour. Consistent use over several weeks may be required for some individuals to observe more sustained benefits.
Typical forms
Tincture, Capsule, Edible, Topical cream/balm, Vape liquid
Quality markers
Key quality markers for CBD oil include third-party lab testing to confirm cannabinoid content and absence of contaminants, such as heavy metals and pesticides. Products should specify the type of extract (e.g., full-spectrum, broad-spectrum, isolate) and the CBD concentration. Reputable brands often provide Certificates of Analysis (COAs).
Medication interactions
  • Blood thinners (e.g., warfarin)
  • Antidepressants
  • Anti-seizure medications
  • Immunosuppressants
  • Medications metabolized by cytochrome P450 enzymes
Avoid if
  • Pregnant or breastfeeding
  • Taking medications with a grapefruit warning
  • History of liver disease
  • Known allergy to cannabis or hemp products

Community tips

No community tips yet — be the first to share what worked for you.

Suggested dosage

10–50 mg CBD, 1–2x/day; titrate up as needed.

General guidance — discuss specifics with a clinician.

Active medicinal compounds

Cannabidiol (CBD), minor cannabinoids, terpenes (in full-spectrum products).

Traditional use

Cannabis has been used medicinally across cultures for thousands of years; CBD isolated in the 1940s.

Safety

Safety warnings

Drowsiness, dry mouth, diarrhea. Quality varies widely — choose third-party tested products.

Avoid if

  • Pregnant or breastfeeding
  • Taking medications with a grapefruit warning
  • History of liver disease
  • Known allergy to cannabis or hemp products

Medication interactions

  • Blood thinners (e.g., warfarin)
  • Antidepressants
  • Anti-seizure medications
  • Immunosuppressants
  • Medications metabolized by cytochrome P450 enzymes

Reported side effects

  • Drowsiness
  • Dry mouth
  • Diarrhea
  • Reduced appetite
  • Fatigue
  • Changes in liver enzyme levels

General guidance — discuss specifics with a clinician.

Evidence ecosystem

Scientific literature, clinical guidance, government sources, ongoing research, traditional use, and lived experience — grouped by source type and quality.

Overall grade (D)

Evidence for CBD's effects includes a growing number of human clinical trials, observational studies, and extensive preclinical research. The evidence grade of B suggests a good body of research supporting some applications, though often with limitations.

Filter by source type

Meta-Analyses(1)

Pooled analyses across multiple human trials.

Very High Quality
  • Cannabis-based medicines and medical cannabis for adults with cancer pain.

    Häuser W, Welsch P, Radbruch L, Fisher E, Bell RF, Moore RA · The Cochrane database of systematic reviews · 2023 · n=10

    Pain is a common symptom in people with cancer; 30% to 50% of people with cancer will experience moderate-to-severe pain. This can have a major negative impact on their quality of life. Opioid (morphine-like) medications are commonly used to treat moderate or severe cancer pain, and are recommended for this purpose in the World Health Organization (WHO) pain treatment ladder. Pain is not sufficiently relieved by opioid medications in 10% to 15% of people with cancer. In people with insufficient relief of cancer pain, new analgesics are needed to effectively and safely supplement or replace opioids. To evaluate the benefits and harms of cannabis-based medicines, including medical cannabis, for treating pain and other symptoms in adults with cancer compared to placebo or any other established analgesic for cancer pain. We used standard, extensive Cochrane search methods. The latest search date was 26 January 2023. We selected double-blind randomised, controlled trials (RCT) of medical

    Meta-AnalysisPubMedVery High Quality

Observational Studies(2)

Cohort, case-control, and cross-sectional human studies.

Moderate Quality
  • Current Cannabidiol Safety: A Review.

    Singh C, Rao K, Yadav N, Vashist Y, Chugh P, Bansal N · Current drug safety · 2023

    Marijuana, also known as cannabis, is the second most widely used illegal psychoactive substance smoked worldwide after tobacco, mainly due to the psychoactive effects induced by D-9-tetrahydrocannabinol (9-THC). Cannabidiol (CBD) is extracted from cannabis and may be used as an anti-inflammatory agent. Some patents on cannabidiol are discussed in this review. The cannabinoid is a non-psychoactive isomer of the more infamous tetrahydrocannabinol (THC); and is available in several administration modes, most known as CBD oil. This study aims to provide an enhanced review of cannabidiol properties used in treating inflammation. This review also emphasises the current safety profile of cannabidiol. Cannabis is also called Marijuana. It is the second most commonly used illegal psychoactive substance in the universe after tobacco. D-9-tetrahydrocannabinol (9-THC) present in cannabis produces psychoactive effects. Cannabidiol (CBD) extracted from cannabis is used for antiinflammatory purpos

    Observational StudyPubMedLow Quality
  • Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.

    Legare CA, Raup-Konsavage WM, Vrana KE · Pharmacology · 2022

    There is a growing interest in the use of cannabis (and its extracts), as well as CBD oil (hemp extracts containing cannabidiol), for therapeutic purposes. While there is reason to believe that cannabinoids may be efficacious for a number of different diseases and syndromes, there exist limited objective data supporting the use of crude materials (CBD oil, cannabis extracts, and/or cannabis itself). In the present review, we examined data for pure cannabinoid compounds (dronabinol, nabilone, and CBD), as well as partially purified medicinal cannabis extracts (nabiximols), to provide guidance on the potential therapeutic uses of high-THC cannabis and CBD oil. In general, data support a role for cannabis/cannabinoids in pain, seizure disorders, appetite stimulation, muscle spasticity, and treatment of nausea/vomiting. Given the biological activities of the cannabinoids, there may be utility in treatment of central nervous system disorders (such as neurodegenerative diseases, PTSD, and a

    Observational StudyPubMedLow Quality

Government Health Sources(1)

Public-health agencies: NCCIH, NIH, CDC, NHS.

High Quality

Clinical Trial Registries(1)

Registered ongoing or completed trials (ClinicalTrials.gov).

Moderate Quality
  • A Phase I/Ib Study on the Safety of Epidiolex in Patients With Prostate Cancer With Rising PSA After Localized Therapy With Either Surgery or Radiation

    n=21 · NCT04428203 · COMPLETED · COMPLETED

    The purpose of this phase I/Ib study is to determine the safety profile of Epidiolex (CBD oil) in biochemically recurrent prostate cancer patients. The study consists of a dose escalation part and dose expansion part. The dose expansion part of the study will use the maximum tolerated dose (MTD) determined in the dose escalation part to assess the activity, safety and tolerability of the investigational product in patients with biochemically recurrent prostate cancer after localized therapy with either surgery or radiation.

    Clinical TrialClinicalTrials.govModerate Quality

Limitations: Current research often involves relatively small sample sizes and significant heterogeneity in study designs, participant populations, and CBD product formulations. There is also a lack of long-term safety data and potential for bias due to industry funding in some studies.

This page is educational. Statements use phrases like "may support" and "has been studied for"because no remedy here is approved to cure, treat, or reverse any condition. Discussion happens on the ailment pages — community statistics here are derived from those reports. Always consult a qualified clinician.

Tried CBD Oil?

Help others see what actually works.